Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab
We describe the case of an infant who presented with simple rhinovirus/enterovirus bronchiolitis whose condition worsened with rapid progression to multiple organ dysfunction syndrome (MODS). The patient was presumed to have either primary or secondary hemophagocytic lymphohistiocytosis (HLH), and t...
| Published in: | Frontiers in Pediatrics |
|---|---|
| Main Authors: | Timothy J. Hahn, Daniel J. McKeone, James W. Beal, Jessica E. Ericson, E. Scott Halstead |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-01-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2023.1340360/full |
Similar Items
Efficacy of emapalumab in treating 3 pediatric patients with epstein–barr virus-associated hemophagocytic lymphohistiocytosis complicated by multiple organ dysfunction
by: Gang Liu, et al.
Published: (2025-12-01)
by: Gang Liu, et al.
Published: (2025-12-01)
Successful use of emapalumab in refractory hemophagocytic lymphohistiocytosis in a child with Chédiak–Higashi syndrome: a case report
by: Ali AlAhmari, et al.
Published: (2023-03-01)
by: Ali AlAhmari, et al.
Published: (2023-03-01)
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy
by: Beatrice Manghisi, et al.
Published: (2025-04-01)
by: Beatrice Manghisi, et al.
Published: (2025-04-01)
Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report
by: Mingda Tian, et al.
Published: (2026-06-01)
by: Mingda Tian, et al.
Published: (2026-06-01)
Macrophage activation syndrome successfully treated with eculizumab and emapalumab: a case report
by: Paola Faggioli, et al.
Published: (2025-03-01)
by: Paola Faggioli, et al.
Published: (2025-03-01)
Functional immune profiling of hyper- and hypo-inflammatory subphenotypes of critical illness: a secondary analysis
by: E. Scott Halstead, et al.
Published: (2025-05-01)
by: E. Scott Halstead, et al.
Published: (2025-05-01)
The role of etoposide in the treatment of adult patients with hemophagocytic lymphohistiocytosis
by: Timo C. E. Zondag, et al.
Published: (2023-01-01)
by: Timo C. E. Zondag, et al.
Published: (2023-01-01)
Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia
by: Elizabeth D. Slaney, et al.
Published: (2024-01-01)
by: Elizabeth D. Slaney, et al.
Published: (2024-01-01)
Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms
by: Yijun Wu, et al.
Published: (2024-11-01)
by: Yijun Wu, et al.
Published: (2024-11-01)
Profound hyperferritinemia may not be specific for the diagnosis of haemophagocytic lymphohistiocytosis (HLH) in Asian children
by: Wen Qi Cher, et al.
Published: (2020-09-01)
by: Wen Qi Cher, et al.
Published: (2020-09-01)
Hemophagocytic Lymphohistiocytosis as Initial Presentation of Malignancy in Pediatric Patients: Rare but Not to Be Ignored
by: Hye-ji Han, et al.
Published: (2021-11-01)
by: Hye-ji Han, et al.
Published: (2021-11-01)
Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis
by: Patrick Brossard, et al.
Published: (2024-04-01)
by: Patrick Brossard, et al.
Published: (2024-04-01)
Hemophagocytic lymphohistiocytosis secondary to dengue fever
by: Simon Kashfi, et al.
Published: (2025-02-01)
by: Simon Kashfi, et al.
Published: (2025-02-01)
Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report
by: Tyler Ruemmele, et al.
Published: (2025-04-01)
by: Tyler Ruemmele, et al.
Published: (2025-04-01)
Comprehensive insights into tuberculosis-associated hemophagocytic lymphohistiocytosis: a systematic review
by: Arvin Eslami, et al.
Published: (2024-11-01)
by: Arvin Eslami, et al.
Published: (2024-11-01)
A Rare Initial Presentation in Extra Pulmonary Tuberculosis- Hemophagocytic Lymphohistiocytosis as a Differential Diagnosis
by: U. P. Edirisinghe, et al.
Published: (2022-08-01)
by: U. P. Edirisinghe, et al.
Published: (2022-08-01)
Disseminated histoplasmosis and hemophagocytic lymphohistiocytosis: A case report
by: Ruth C. Angrand, et al.
Published: (2025-01-01)
by: Ruth C. Angrand, et al.
Published: (2025-01-01)
A retrospective analysis of 56 children with hemophagocytic lymphohistiocytosis
by: Wang Y, et al.
Published: (2016-10-01)
by: Wang Y, et al.
Published: (2016-10-01)
Hemophagocytic lymphohistiocytosis: pediatric hepatic perspective
by: Manal Hamdy El-Sayed, et al.
Published: (2024-10-01)
by: Manal Hamdy El-Sayed, et al.
Published: (2024-10-01)
Editorial: Towards a better understanding of hemophagocytic lymphohistiocytosis
by: Sabrin Albeituni
Published: (2024-04-01)
by: Sabrin Albeituni
Published: (2024-04-01)
Etoposide‐based treatment of adult HLH is associated with high biochemical response but poor survival outcomes
by: Matthew C. Nicholson, et al.
Published: (2020-07-01)
by: Matthew C. Nicholson, et al.
Published: (2020-07-01)
Low-dose emapalumab treatment in refractory macrophage activation syndrome secondary to adult onset still’s disease/systemic lupus erythematosus: insights from nine cases
by: Jie Chen, et al.
Published: (2025-10-01)
by: Jie Chen, et al.
Published: (2025-10-01)
Hemophagocytic Lymphohistiocytosis Triggered by Dengue: A Narrative Review and Individual Patient Data Meta-Analysis
by: Angelos Sourris, et al.
Published: (2025-07-01)
by: Angelos Sourris, et al.
Published: (2025-07-01)
Emapalumab in Patients With Macrophage Activation Syndrome Associated With Still's Disease: A Population Pharmacokinetic/Pharmacodynamic Analysis
by: Patrick Brossard
Published: (2025-02-01)
by: Patrick Brossard
Published: (2025-02-01)
Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis
by: William T. Johnson, et al.
Published: (2024-05-01)
by: William T. Johnson, et al.
Published: (2024-05-01)
Adult secondary hemophagocytic lymphohistiocytosis
by: Antonina Obayo, et al.
Published: (2020-11-01)
by: Antonina Obayo, et al.
Published: (2020-11-01)
Successful Treatment of Severe Steroid-Resistant Engraftment Syndrome Following Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia with Emapalumab: A Case Report
by: Tian Z, et al.
Published: (2024-06-01)
by: Tian Z, et al.
Published: (2024-06-01)
Hemophagocytic lymphohistiocytosis Secondary to Epstein–Barr Virus presenting as Rhabdomyolysis
by: Zachary Holtzapple, et al.
Published: (2025-06-01)
by: Zachary Holtzapple, et al.
Published: (2025-06-01)
Evaluating hemophagocytic lymphohistiocytosis criteria in patients with drug-induced hypersensitivity syndrome
by: Hannah Bulosan, BS, et al.
Published: (2025-09-01)
by: Hannah Bulosan, BS, et al.
Published: (2025-09-01)
Haemophagocytic lymphohistiocytosis and liver failure-induced massive hyperferritinaemia in a male COVID-19 patient
by: Núria M. Zellweger, et al.
Published: (2021-01-01)
by: Núria M. Zellweger, et al.
Published: (2021-01-01)
Comparison of whole blood cytokine immunoassays for rapid, functional immune phenotyping in critically ill patients with sepsis
by: Anthony S. Bonavia, et al.
Published: (2023-10-01)
by: Anthony S. Bonavia, et al.
Published: (2023-10-01)
Secondary hemophagocytic lymphohistiocytosis in a child with Sickle Cell Anemia and Hepatitis A and Hepatitis E co-infection: A case report
by: Govind Choudhary, et al.
Published: (2024-03-01)
by: Govind Choudhary, et al.
Published: (2024-03-01)
Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children
by: Anshul Vagrecha, et al.
Published: (2022-03-01)
by: Anshul Vagrecha, et al.
Published: (2022-03-01)
A mild, self-resolving case of Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis
by: Biplov Adhikari, et al.
Published: (2022-01-01)
by: Biplov Adhikari, et al.
Published: (2022-01-01)
Fatal case of EBV induced hemophagocytic lymphohistiocytosis (HLH), presenting with acute abdomen
by: Gina Rami Salama Ibrahim Abdelmesih
Published: (2024-03-01)
by: Gina Rami Salama Ibrahim Abdelmesih
Published: (2024-03-01)
Assessment of CD38brightHLA-DR+ T cells using a rapid flow cytometry-based assay to aid in the diagnosis of hemophagocytic lymphohistiocytosis and immune regulatory disorders in adult subjects
by: Aaruni Khanolkar, et al.
Published: (2025-12-01)
by: Aaruni Khanolkar, et al.
Published: (2025-12-01)
Management of Refractory Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adolescent Patients: A Case Series of Novel Therapeutics and Treatment Challenges
by: Meha Krishnareddigari, et al.
Published: (2025-05-01)
by: Meha Krishnareddigari, et al.
Published: (2025-05-01)
Deciphering the clinical profile and diagnostic framework of hemophagocytic lymphohistiocytosis in a tertiary care setting
by: Lipsa Priyadarshini, et al.
Published: (2024-12-01)
by: Lipsa Priyadarshini, et al.
Published: (2024-12-01)
Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature
by: Jaime Rubio-Perez, et al.
Published: (2022-10-01)
by: Jaime Rubio-Perez, et al.
Published: (2022-10-01)
Approaching hemophagocytic lymphohistiocytosis
by: Aurora Chinnici, et al.
Published: (2023-06-01)
by: Aurora Chinnici, et al.
Published: (2023-06-01)
Similar Items
-
Efficacy of emapalumab in treating 3 pediatric patients with epstein–barr virus-associated hemophagocytic lymphohistiocytosis complicated by multiple organ dysfunction
by: Gang Liu, et al.
Published: (2025-12-01) -
Successful use of emapalumab in refractory hemophagocytic lymphohistiocytosis in a child with Chédiak–Higashi syndrome: a case report
by: Ali AlAhmari, et al.
Published: (2023-03-01) -
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy
by: Beatrice Manghisi, et al.
Published: (2025-04-01) -
Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report
by: Mingda Tian, et al.
Published: (2026-06-01) -
Macrophage activation syndrome successfully treated with eculizumab and emapalumab: a case report
by: Paola Faggioli, et al.
Published: (2025-03-01)
